Market Overview

RBC Capital Initiates Coverage on Marinus Pharmaceuticals at Outperform, Announces $14.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MRNS

DateFirmActionFromTo
Aug 2016JefferiesMaintainsBuy
Jun 2016JefferiesMaintainsBuy
Jun 2016RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for MRNS
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (MRNS)